caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1972554459

Xylina GreggM.D.

Medical OncologySalt Lake City, UTI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,744
Unique beneficiaries
—
Total services
34,316
Distinct HCPCS
44
Medicare payment
$593K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 38 Medical Oncology providers in UT — top quintile (cohort median 725).
REFERRAL NETWORK

Where Xylina Gregg's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 11 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
NORTHERN UTAH HEALTHCARE CORPORATION114570
IHC HEALTH SERVICES, INC.90507
Jonathan Naatz
Diagnostic Radiology · Lynnwood, WA
2168
CARPENTER, CRAIG2049
SMITH, GREGORY1956
Gregory Litton
Medical Oncology · Murray, UT
17190
Catherine Bowles
Pathology · Salt Lake City, UT
1641
Charles Swallow
Diagnostic Radiology · Grand Rapids, MI
1228
Gregory Miller
Physical Medicine and Rehabilitation · Saint Helena, CA
1180
Roy Bonk
Diagnostic Radiology · Sacramento, CA
1137
Cole Panushka
Diagnostic Radiology · Farmington, UT
1135
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
739
Beneficiaries
—
Total drug cost
$3.5M
Distinct drugs
26
Brand share
33.2%
Top prescribed drugs
Anastrozole183 claims
Tamoxifen Citrate100 claims
Hydroxyurea40 claims
Ibrutinib36 claims
Acyclovir28 claims
QUALITY · MIPS · 2024
Final MIPS score
86.9
Quality
77.3
Cost
77.6
Improvement activities
40.0
Promoting interop.
90.0
Payment adjustment
0.50%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$5K
Payment records
70
By payment type
Food and Beverage$2K
Honoraria$2K
Consulting Fee$1K
Education$99